Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature Medicine 10, 1067 - 1073 (2004)
Published online: 26 September 2004 | doi:10.1038/nm1106
Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway
Reiko Hanada1,2, Hitoshi Teranishi1, James Todd Pearson3, Mamoru Kurokawa4, Hiroshi Hosoda5, Nobuhiro Fukushima1, Yoshihiko Fukue1, Ryota Serino6, Hiroaki Fujihara6, Yoichi Ueta6, Masahito Ikawa7, Masaru Okabe7, Noboru Murakami8, Mikiyasu Shirai3, Hironobu Yoshimatsu2, Kenji Kangawa5 & Masayasu Kojima1
Abstract
Neuromedin U (NMU) is a hypothalamic neuropeptide that regulates body weight and composition. Here we show that mice lacking the gene encoding NMU (Nmu-/- mice) develop obesity. Nmu-/- mice showed increased body weight and adiposity, hyperphagia, and decreased locomotor activity and energy expenditure. Obese Nmu-/- mice developed hyperleptinemia, hyperinsulinemia, late-onset hyperglycemia and hyperlipidemia. Notably, however, treatment with exogenous leptin was effective in reducing body weight in obese Nmu-/- mice. In addition, central leptin administration did not affect NMU gene expression in the hypothalamus of rats. These results indicate that NMU plays an important role in the regulation of feeding behavior and energy metabolism independent of the leptin signaling pathway. These characteristic functions of NMU may provide new insight for understanding the pathophysiological basis of obesity.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Adiponectin acts in the brain to decrease body weightNature Medicine Article (01 May 2004)
See all 38 matches for Research